Riskpilot← Back to searchSign inGet full accessOrkla Wound Care AB
ABActiveOrg 5567651756Svetsarvägen 15Wholesale of pharmaceutical and medical goods · NACE 4646Est. 200842 employees
Revenue 2024
SEK 363,7M
+11% vs 2023
EBITDA margin
28.1%
+6% vs 2023
Equity ratio
21.4%
Financial strength
Net profit 2024
SEK 45,2M
+4% vs 2023
| Revenue | SEK 363,7M | +11% |
| EBITDA | SEK 102,1M | +6% |
| Net profit | SEK 45,2M | +4% |
| Total assets | SEK 668,8M | +5% |
| Equity | SEK 143,3M | +46% |
| Employees | 42 | — |
Legal name
Orkla Wound Care AB
Org number
5567651756
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
9 september 2008
Share capital
SEK 100 000
Employees
42 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas i förening av externa firmatecknarna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget har till föremål för sin verksamhet att direkt eller indirekt utveckla, tillverka, marnadsföra och/eller distribuera/försälja kemisk-tekniska produkter, medicintekniska och farmaceutiska produkter inom sårvård och första hjälpen för såväl industriella ändamål som privat konsumtion, samt äga och förvalta såväl fast som lös egendom, och bedriva därmed förenlig verksamhet.
Address
Svetsarvägen 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 188 822 | 328 604 | 363 689 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −1 | — | 43 672 | 96 739 | 102 064 |
| Depreciation & amort. | −0 | −0 | −2 013 | −3 087 | −2 782 |
| EBIT | −1 | 0 | 41 659 | 93 652 | 99 282 |
| Net financials | — | — | 22 605 | −12 299 | −17 104 |
| Profit before tax | −1 | 0 | 60 438 | 55 399 | 57 422 |
| Tax | −0 | −0 | −5 893 | −12 112 | −12 203 |
| Net profit | −1 | 0 | 54 545 | 43 287 | 45 219 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 245 | 245 | 560 089 | 638 301 | 668 779 |
| Equity | 245 | 245 | 54 790 | 98 077 | 143 296 |
| Long-term debt | 0 | 0 | 420 613 | 433 862 | 392 784 |
| Short-term debt | 0 | 0 | 74 337 | 64 899 | 60 915 |
| Total debt | — | — | 494 950 | 498 761 | 453 699 |
EBITDA margin
28.1%
This company
15.8%
Market median
+78% vs market
20202024
Equity ratio
21.4%
This company
38.2%
Market median
-44% vs market
20202024
Return on equity
31.6%
This company
18.4%
Market median
+72% vs market
20202024
Net profit margin
12.4%
This company
8.1%
Market median
+53% vs market
20202024
Asset turnover
0.54×
This company
1.12×
Market median
-52% vs market
20202024
Debt / equity
3.67×
This company
0.62×
Market median
-492% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
JO External Signatory | External Signatory | 2022 |
BM Chief Executive Officer | Chief Executive Officer | 2025 |
SC External Signatory | External Signatory | 2022 |
AE Chief Auditor | Chief Auditor | 2022 |
KA External Signatory | External Signatory | 2025 |
| Former (3) | ||
GE External Signatory | External Signatory | 2022 – 2025 |
MK Chief Executive Officer | Chief Executive Officer | 2022 – 2025 |
MM Authorized Recipient of Service | Authorized Recipient of Service | 2020 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2025 | |
| Chairman | 2025 | |
| Former (10) | ||
| Chairman | 2023 – 2024 | |
| Board of Directors | 2024 – 2025 | |
| Board of Directors | 2023 – 2024 | |
| Chairman | 2020 – 2022 | |
| Chairman | 2023 – 2023 | |
| Deputy Board Member | 2020 – 2023 | |
| Board of Directors | 2023 – 2023 | |
| Board of Directors | 2022 – 2023 | |
| Chairman | 2022 – 2023 | |
| Deputy Board Member | 2023 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ORKLA HEALTH HOLDING AS
Orkla Wound Care AB (this company)NORGESPLASTER ASNorgesplaster ASOrkla Cederroth SauORKLA CEDERROTH SAUBoard members of Orkla Wound Care AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Ola Carlstein | External Signatory | 0 companies |
| Börje Mats Palmquist | Chief Executive Officer | 0 companies |
| Gunilla Elisabet Schlyter Hägglund | External Signatory | 0 companies |
| Sara Christina Selander Björklund | External Signatory | 0 companies |
| Maria Kristina Lundman Hedberg | Chief Executive Officer | 0 companies |
| Mina Maria Andersdotter Langendahl | Authorized Recipient of Service | 0 companies |
| Annika Elisabeth Engström | Chief Auditor | 0 companies |
| Kim Alexander Kastensson | External Signatory | 0 companies |
| Louise Agnes Marie Wassberg | Deputy Board Member | 0 companies |
| Isabelle Valerie G Ducellier | Chairman | 0 companies |
| Shaher Yar Kahn | Board of Directors | 0 companies |
| Anette Grane Kringlegarden | Board of Directors | 0 companies |
| Johannes Arbo Høeg | Chairman | 0 companies |
| Are Nakkim | Chairman | 0 companies |
| Erik Smith-Hansen | Deputy Board Member | 0 companies |
| Sara Johanna Sundén | Board of Directors | 0 companies |
| Christian Rykke | Chairman | 0 companies |
| Marte Kaarbø Mathisen | Board of Directors | 0 companies |
| Hege Holter Brekke | Chairman | 0 companies |
| Karolina Grønås Henriksen | Deputy Board Member | 0 companies |